logo

For the Inventor, By the Inventor

Haifa, Israel

Pluristem Ltd.


USPTO Granted Patents = 21

% Expired Patents = 4.8



Forward Citations = 234

Loading Chart...
Loading Chart...

30 inventors (with patents filed for the assignee):

goldMedal Harel Kasuto (6 out of 6 patents)

silverMedal Rachel Ofir (6 out of 6 patents)

bronzeMedal Moran Meiron (6 out of 6 patents)

4.  Eytan Abraham (6 out of 18 patents)

5.  Zami Aberman (5 out of 6 patents)

6.  Amir Toren (5 out of 5 patents)

7.  Nirit Drori-Carmi (5 out of 5 patents)

8.  Lior Raviv (3 out of 7 patents)

9.  Nirit Drori-carmi (2 out of 2 patents)

10.  Barak Zohar (2 out of 2 patents)

11.  Ohad Karnieli (2 out of 2 patents)

12.  Georg N Duda (1 out of 12 patents)

13.  Avinoam Kadouri (1 out of 6 patents)

14.  Raphael Gorodetsky (1 out of 14 patents)

15.  Nadav Eshkol (1 out of 1 patent)


21 patents:

1. 10851347 - Altered adherent stromal cells and methods of producing and using same (2020-12-01),
2. 10851341 - Methods and systems for harvesting cells (2020-12-01),
3. 10722541 - Methods for treating radiation or chemical injury (2020-07-28),
4. 10610545 - Adherent cells from placenta and use of same in disease treatment (2020-04-07),
5. 10392593 - Systems and methods for growing and harvesting cells (2019-08-27),
6. 10351910 - Gene and protein expression properties of adherent stromal cells cultured in 3D (2019-07-16),
7. 10258652 - Methods and compositions for treating and preventing muscle wasting disorders (2019-04-16),
8. 10251389 - Method and device for thawing biological material (2019-04-09),
9. 9950014 - Methods for prevention and treatment of preeclampsia (2018-04-24),
10. D802157 - Carrier for cell culture (2017-11-07),
11. D800334 - Carrier for cell culture (2017-10-17),
12. 9758762 - Perfusion bioreactor for culturing CD200—placenta adherent cells (2017-09-12),
13. 9757419 - Skeletal muscle regeneration using mesenchymal system cells (2017-09-12),
14. 9657266 - Methods and systems for harvesting cells (2017-05-23),
15. 9517248 - Adherent cells from adipose or placenta tissues and use thereof in therapy (2016-12-13),
Company Overview
Pluristem Ltd. is a biotechnology company based in Haifa, Israel, specializing in the development of cell therapy products derived from placental cells. The company focuses on innovative solutions for various medical conditions, leveraging its proprietary PLX (Placental Expanded) cell technology platform. Pluristem's research encompasses regenerative medicine and advanced therapies aimed at treating serious diseases, including those related to the immune system and muscle injuries, positioning it at the forefront of the biopharmaceutical industry.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

21 Patents

#13 in Haifa

#287 in Israel

#29,928 in the World

Haifa, IL
Haifa, Israel

Pluristem Ltd.

Forward Citations = 234

30 inventors:

goldMedal Harel Kasuto (6 out of 6 patents)

silverMedal Rachel Ofir (6 out of 6 patents)

bronzeMedal Moran Meiron (6 out of 6 patents)

4.  Eytan Abraham (6 out of 18 patents)

5.  Zami Aberman (5 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pluristem Ltd.. Retrieved from https://idiyas.com/company/pluristem

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…